Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Protopic (tacrolimus 0.1%) for varicose eczema: open-label pilot study
2004-004467-29Phase 4Completed
- Sponsor
- Craigavon Area Hospital Group Trust
- Start
- Jul 2005
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Envarsus XR in Stasis Dermatitis (SD), sponsored by Craigavon Area Hospital Group Trust. Primary endpoint: Change in number of active varicose eczema lesions from baseline to study completion. Started Jul 2005; status: completed.
02
Drugs
Envarsus XR
03
Conditions
Stasis Dermatitis (SD)
Beyond the preview
Go deeper on 2004-004467-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004467-29.